Colesevelam Hcl
1 NDC across 1 manufacturer|1 Generic,0 Brand
Colesevelam Hcl is used to treat coronary artery disease, type 2 diabetes mellitus, diarrhea, pseudomembranous enterocolitis, hypercholesterolemia and hyperlipoproteinemias, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $53 million on Colesevelam Hcl across 266,000 claims for 74,000 beneficiaries.
Colesevelam Hcl is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.26 to $0.26 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.26 – $0.26
per EA
7d Activity
avg -2.6% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing COLESEVELAM HCL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COLESEVELAM 625 MG TABLET | $0.2608 per EA | -2.61% |
Frequently Asked Questions
What is Colesevelam Hcl used to treat?
Colesevelam Hcl is used to treat coronary artery disease, type 2 diabetes mellitus, diarrhea, pseudomembranous enterocolitis, hypercholesterolemia and hyperlipoproteinemias, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Colesevelam Hcl?
In 2024, Medicare Part D spent $53 million on Colesevelam Hcl across 266,000 claims for 74,000 beneficiaries.
How many Colesevelam Hcl products are on the market?
The Colesevelam Hcl drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Colesevelam Hcl?
NADAC reference prices for Colesevelam Hcl range from $0.2608 to $0.2608 per EA.
Which manufacturers make Colesevelam Hcl?
1 manufacturer lists Colesevelam Hcl in NADAC. Ranked by number of NDCs, the largest are Ascend Laboratories, LLC (1).
How has the price of Colesevelam Hcl changed recently?
Over the past 7 days, 0 Colesevelam Hcl NDCs rose and 1 fell, with a market-wide average change of -2.6%.